This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Mersana Therapeutics, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Ling Xu: Innovator in Antibody Drug Conjugates
Introduction
Ling Xu is a prominent inventor based in Brookline, MA (US), known for her significant contributions to the field of biotechnology. With a total of 2 patents to her name, she has made remarkable strides in the development of innovative therapies.
Latest Patents
Her latest patents focus on antibody drug conjugates (ADCs) that incorporate stimulators of interferon genes (STING). These ADCs are designed for therapeutic applications, particularly in the treatment of cancer. The disclosures highlight the potential of these innovative drug conjugates to enhance treatment efficacy.
Career Highlights
Ling Xu is currently associated with Mersana Therapeutics, Inc., where she continues to push the boundaries of cancer treatment through her research and inventions. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of her notable coworkers include Jeremy R. Duvall and Keith W. Bentley, who collaborate with her in the pursuit of groundbreaking innovations in the field.
Conclusion
Ling Xu's contributions to the development of antibody drug conjugates represent a significant advancement in cancer therapy. Her work exemplifies the impact of innovative thinking in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile